Iovance Biotherapeutics Inc (IOVA)

[microcapbiotech]

If in March we get the FDA hold lifted ... and let's say that pushes the price past $20, which I think is more than reasonable, with just the rest of their pipeline which is using the Same therapy that is already proven and approved, that should be worth what? Somewhere between $30 and $40.
So seriously, IF BEFORE we even factor in ever increasing revenues that will be coming in, any buy out offer would have to be north of $50, perhaps well north.